SEC Form 4 · accession 0001615774-17-004013
Inspyr Therapeutics, Inc. · NSPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter E Grebow
Director
Period of report
May 23, 2017
Accepted (ET)
Aug 2, 2017 · 1:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421204
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $0.41 | May 23, 2017 | A | 2,335 | A | May 23, 2017 | May 23, 2022 | Common Stock | 2,335 | 2,335 | D |
Explanation of responses
- F1Represents compensatory Annual Grant and Committee Grants for director services. The options vest quarterly on 8/23/17, 11/23/17, 2/23/18, and 5/23/18.